(NASDAQ: PEPG) Pepgen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.75%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.32%.
Pepgen's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast PEPG's revenue for 2025 to be $651,142,246, with the lowest PEPG revenue forecast at $651,142,246, and the highest PEPG revenue forecast at $651,142,246. On average, 1 Wall Street analysts forecast PEPG's revenue for 2026 to be $2,441,620,474, with the lowest PEPG revenue forecast at $2,441,620,474, and the highest PEPG revenue forecast at $2,441,620,474.
In 2027, PEPG is forecast to generate $1,862,664,418 in revenue, with the lowest revenue forecast at $270,820,424 and the highest revenue forecast at $3,454,508,412.